The Pelargonium genus encompasses around 280 species, most of which are used for medicinal purposes. While P. graveolens, P. odoratissimum, and P. zonale are known to exhibit antimicrobial activity, there is an evident absence of studies evaluating all three species to understand their chemical differences and biological effects. Through the analysis of the hydroalcoholic extracts of P. graveolens, P. odoratissimum, and P. zonale, using HPLC-DAD-MS/MS, quercetin and kaempferol derivatives were identified in these three species. Conversely, gallotannins and anthocyanins were uniquely detected in P. zonale. P. graveolens stood out due to the various types of myricetin derivatives that were not detected in P. odoratissimum and P. zonale extracts. Evaluation of their biological activities revealed that P. zonale displayed superior antibacterial and antibiofilm activities in comparison to the other two species. The antibacterial efficacy of P. zonale was observed towards the clinically relevant strains of Staphylococcus aureus ATCC 25923, Methicillin-resistant Staphylococcus aureus (MRSA) 333, Enterococcus faecalis ATCC 29212, and the Vancomycin-resistant E. faecalis INSPI 032. Fractionation analysis of P. zonale suggested that the antibacterial activity attributed to this plant is due to the presence of quercetin derivatives and kaempferol and its derivatives, alongside their synergistic interaction with gallotannins and anthocyanins. Lastly, the three Pelargonium species exhibited notable antioxidant activity, which may be attributed to their high content of total phenolic compounds.

The Pelargonium genus, encompassing over 280 species, remains markedly underexplored despite extensive traditional use for respiratory, gastrointestinal, and dermatological disorders. This review of aqueous, alcoholic, and hydroalcoholic extracts reveals critical research gaps: only 10 species have undergone chemical characterization, while 17 have been evaluated for biological activities. Phytochemical analysis identified 252 unique molecules across all studies, with flavonoids emerging as the predominant class (n = 108). Glycosylated derivatives demonstrated superior bioactivity profiles compared to non-glycosylated analogs. Phenolic acids (n = 43) and coumarins (n = 31) represented additional major classes. Experimental studies primarily documented antioxidant, antibacterial, and anti-inflammatory effects, with emerging evidence for antidiabetic, anticancer, and hepatoprotective activities. However, methodological heterogeneity across studies limits comparative analysis and comprehensive understanding. In silico target prediction analysis was performed on 197 high-confidence molecular structures. Glycosylated flavonols, anthocyanidins, flavones, and coumarins showed strong predicted interactions with key inflammatory targets (ALOX15, ALOX5, PTGER4, and NOS2) and metabolic regulators (GSK3A and PI4KB), providing mechanistic support for observed therapeutic effects and suggesting potential applications in chronic inflammatory and metabolic diseases. These findings underscore the substantial therapeutic potential of underexplored Pelargonium species and advocate for systematic research employing untargeted metabolomics, standardized bioassays, and compound-specific mechanistic validation to fully unlock the pharmacological potential of this diverse genus.

This study investigates the valorization of Nephelium lappaceum (rambutan) shell, an agro-industrial byproduct, as a sustainable source of bioactive compounds through comprehensive chemical and functional characterization. Phytochemical profiles were determined using spectrophotometrics and HPLC-DAD-MS/MS, revealing a composition dominated by ellagitannins (e.g., geraniin, corilagin, chebulagic acid) and ellagic acid derivatives, alongside significant levels of total phenolics (25,982.2 mg/100 g DW) and anthocyanins. The extract exhibited strong antioxidant activity (DPPH IC₅₀ = 8.02 μg/mL; TEAC = 5703.92 μmol TE/g), consistent with its high phenolic content. Biological evaluation demonstrated antimicrobial activity against a broad panel of Gram-positive and Gram-negative bacteria, including multidrug-resistant strains, with greater efficacy against Gram-positive species (Staphylococcus aureus, MIC = 2.5 mg/mL). The extract also showed significant antibiofilm activity, achieving up to 93% inhibition. Antitumoral assays revealed selective cytotoxicity, particularly against HeLa cells (IC₅₀ = 260 μg/mL; TI = 11.5), indicating preferential effects on tumor over non-tumor cells. Importantly, hemolytic assays confirmed low toxicity, with negligible erythrocyte membrane disruption across tested concentrations. Overall, these findings highlight rambutan shell as a rich source of phenolic bioactives with multifunctional biological properties and favorable safety profile, supporting its potential application in nutraceutical and pharmaceutical formulations within a circular economy framework. This study aligns with SDG 3 and SDG 9 by promoting the valorization of agro-industrial waste as a source of safe bioactive compounds for health-related applications.

El objetivo de la presente investigación fue identificar las fortalezas y debilidades en la gestión financiera y administrativa para proponer mejoras. El diseño es no experimental transversal, a causa de que no se manipula ninguna variable independiente. Los resultados del estudio realizado sobre la realización de la gestión para los recursos financieros y la eficiencia administrativa de la Cooperativa Indígena SAC LTDA. de Latacunga sugieren que, aunque la cooperativa ha logrado avances importantes en la gestión de sus recursos, aún enfrenta varios retos en términos de eficiencia y sostenibilidad financiera. La cooperativa, como entidad de economía social, ha demostrado un fuerte compromiso con el bienestar de sus miembros y la comunidad indígena a la que pertenece. En conclusión, que la participación de los socios y una mayor transparencia en la toma de decisiones son factores clave para fortalecer la confianza en la gestión de la cooperativa.

Lepidium meyenii and Bactris gasipaes are traditionally consumed plant foods with documented antioxidant and inflammation-related activities and emerging evidence of cancer-related biological effects. Accordingly, we compared the antitumor-relevant activity of these chemically distinct extracts and evaluated the effect of microencapsulation. Liquid extracts were chemically characterized, spray-dried with maltodextrin- or maltodextrin–gum arabic, and evaluated in tumor and non-tumor cell models, with antioxidant and inflammation-related endpoints as complementary responses; L. meyenii was further examined by bioactivity-guided fractionation. Chemical characterization confirmed that L. meyenii was enriched in organic acids, phenolics, and alkaloids, whereas B. gasipaes was dominated by carotenoids. B. gasipaes liquid extract showed lower IC₅₀ values (0.27–0.63 mg/mL), whereas L. meyenii liquid extract showed higher calculated therapeutic indices (2.28–3.64). Both extracts showed encapsulation efficiencies above 97%, with microencapsulation generally reducing antiproliferative potency. Bioactivity-guided fractionation associated the strongest tumor-cell responses with L. meyenii fractions containing signals putatively annotated as lepidilines A, B, and D. Additionally, L. meyenii extract reduced LPS-induced nitric oxide production without reproducing a broad LPS-like transcriptional response. These findings support further studies to evaluate enriched constituents, clarify mechanisms across broader cell models, and explore spray-dried carrier behavior during storage and reconstitution.

The Ericaceae family encompasses several berries with recognized health-promoting properties; however, Macleania rupestris, a neotropical species endemic to the Andean region, remains poorly characterized. Background/Objectives: This study aimed to identify the chemical composition of M. rupestris ethanolic extracts and evaluate their biological activities, including antitumoral, hemolytic, anti-inflammatory, and leishmanicidal effects. Methods: The M. rupestris ethanolic extracts were obtained from lyophilized fruits and analyzed by HPLC-MS/MS for phytochemical profiling. Bioactivities were assessed in vitro using tumor and non-tumor cell lines (MTT assay), erythrocyte hemolysis assays, RAW 264.7 macrophage inflammation models, and Leishmania mexicana promastigotes. Results: The chemical analysis revealed anthocyanins (cyanidin-3-glucoside, malvidin-3-glucoside, petunidin-3-glucoside, delphinidin-3-arabinoside), flavonols (quercetin and myricetin derivatives), and coumaroyl iridoids. The extract showed modest antiproliferative activity (IC₅₀ 10.4–22.5 mg/mL) across tumor cell lines with low therapeutic indices, indicating limited selectivity. In contrast, hemolytic activity was negligible (<5% at all tested concentrations), suggesting high biocompatibility. Anti-inflammatory assays indicated a dose-dependent reduction in nitric oxide (NO) production, while no significant leishmanicidal activity was detected. Conclusions: This study provides the first comprehensive evaluation of the previously listed M. rupestris bioactivities. While its antitumoral effects appear limited, its strong hemocompatibility and presence of antioxidant metabolites highlight its potential for biomedical and nutraceutical applications where biocompatibility is critical. Further studies are needed to optimize bioactivity and explore potential synergistic effects.